Fangda acts on Chaoju Eye Care’s HKD1.81 billion Hong Kong listing and global offering

Fangda acted as Hong Kong and US counsel to Chaoju Eye Care Holdings Limited (Stock code: 2219) on the listing of Chaoju Eye Care’s ordinary shares on the Main Board of the Stock Exchange of Hong Kong and the concurrent global offering. The listing and global offering raised approximately HK$1.81 billion (prior to exercise of the underwriters’ over-allotment option).

Chaoju Eye Care is a leading ophthalmic medical service group in North China with a strong reputation nationwide. Since the inception, Chaoju Eye Care has adhered to the vision of “taking our century’s heritage to bring light to the world and inspire hope” and provided patients with safe, reassuring and affordable ophthalmic medical experience with professional and effective equipment and technology as well as caring and considerate services.

The listing and the closing of the global offering took place on July 7, 2021. Haitong and Huatai acted as joint sponsors of the listing, as well as joint global coordinators, joint bookrunners and joint lead managers of the global offering.

The Fangda team was led by partners Peter Chen, Christine Chen and Arman Lie and the team members comprised of associates Brian Kwok, Siyu You, Ning Linzy, trainee Lizzie Cheong and paralegal Andrew Chan.